[1]黄丽娟,陈宁,叶静,等.反义肽核酸对促甲状腺激素受体mRNA表达的影响[J].国际放射医学核医学杂志,2012,36(5):310-312,319.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.011]
 HUANG Li-juan,CHEN Ning,YE Jing,et al.The effects of antisense peptide nucleic acid on the expression of thyroid stimulating hormone receptor mRNA[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):310-312,319.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.011]
点击复制

反义肽核酸对促甲状腺激素受体mRNA表达的影响(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
36
期数:
2012年第5期
页码:
310-312,319
栏目:
分子生物学
出版日期:
1900-01-01

文章信息/Info

Title:
The effects of antisense peptide nucleic acid on the expression of thyroid stimulating hormone receptor mRNA
作者:
黄丽娟1 陈宁2 叶静2 沈炳玲2 朱云娟3 孟涛1 张志洋1 朱学良2
1. 天健生物制药(天津)有限公司, 天津 300457;
2. 天津医科大学病理生理教研室, 天津 300070;
3. 天津医科大学寄生虫学教研室, 天津 300070
Author(s):
HUANG Li-juan1 CHEN Ning2 YE Jing2 SHEN Bing-ling2 ZHU Yun-juan3 MENG Tao1 ZHANG Zhi-yang1 ZHU Xue-liang2
TianJian Biotechnologies(Tianjin) Limited Company, Tionjin 300457, China
关键词:
肽核酸类受体促甲状腺素RNA信使
Keywords:
Peptide nucleic acidsReceptorsthyrotropinRNAmessenger
DOI:
10.3760/cnla.j.issn.1673-4114.2012.05.011
摘要:
目的 探讨反义肽核酸(asPNA)对大鼠甲状腺细胞的细胞膜表面促甲状腺激素受体(TSHR)表达的影响。方法 设计两种与TSHR mRNA不同片段互补的asPNA,分别为核定位信号-asPNA 1(NLS-asPNA1)和NLS-asPNA2,另外合成一段非相关的干扰肽核酸(NLS-scrPNA)序列,用荧光显微镜观察NLS-asPNA能否进入细胞,采用噻唑蓝法检测asPNA对细胞是否具有毒性作用,然后用实时定量RT-PCR检测NLS-asPNA对TSHR mRNA表达的影响。结果 荧光显微镜观察发现,asPNA可以进入到细胞中去.噻唑蓝法检测发现asPNA对细胞没有毒性作用.实时定量RT-PCR结果显示,NLS-asPNA1和NLS-asPNA2可以抑制TSHR mRNA表达,表现为随着NLS-asPNA与细胞培养时间的延长,TSHR cDNA的拷贝数逐渐下降,且呈现时间依赖性,而NLS-scrPNA对TSHRmRNA的表达没有明显的影响。结论 NLS-asPNA可以进入到细胞中去,并且能够下调TSHRmRNA的表达.
Abstract:
Objective To study the effects of antisense peptide nucleic acid(asPNA) on thyroid stimulating hormone receptor(TSHR) of Fisher rat thyroid cells membrane.Methods Two kinds of asPNA which could hybridized to the TSHR mRNA named as nuclear localization signal-asPNA1 (NLS-asPNA1) and NLS-asPNA2 were designed,and a control PNA with a scramble sequence named as NLS-scrPNA was synthetized.The cellular uptake of peptide nucleic acids were analyzed by fluorescence microscopy,and the toxic effect of asPNA to Fisher rat thyroid cells was evaluated by MTT assay.The effect of NLS-asPNA on the expression of TSHR mRNA was detected by realtime quantitative RT-PCR.Results Fluorescence microscopy indicated that asPNA were taken up by the cells.The results of MTT assay showed that all the asPNA had no toxic effect on the cells.The results of realtime quantitative RT-PCR showed that NLS-asPNA1 and NLS-asPNA2 could inhibit the expression of TSHR mRNA,the copies of TSHR cDNA decreased gradually along with the prolongation of culture time.But NLS-scrPNA had no significant effect on the expression of TSHR mRNA.Conclusion NLS-asPNA could be taken up by the cells and down-regulate the expression of TSHR mRNA.

参考文献/References:

[1] Nielsen PE, Egholm M, Berg RH, et al. Sequence-selective recognition of DNA by strand displacement with a thymine-substitutedpolyamide. Science, 1991, 254(5037):1497-1500.
[2] Egholm M, Buchardt O, Nielsen PE, et al. Peptide nucleic acids (PNA). Oligonucleotide analogs with an achiral peptide backbone. J Am Chem Soc, 1992, 114(5):1895-1897.
[3] Eghohn M, Buchardt O, Christensen L, et al. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature, 1993,365(6446):566-568.
[4] Filipovska A, Eccles MR, Smith RA, et al. Delivery of antisense peptide nucleic acids (PNAs) to the cytosol by disulphide conjugation to a lipophilic cation. FEBS Lett, 2004, 556(1-3):180-186.
[5] Boules M, Williams K, Gollatz E, el aL Down-regulation of amyloid precursor protein by peptide nucleic acid in vivo. J Mol Neurosei, 2004, 24(1):123-128.
[6] Karras JG, Maier MA, Lu T, et al. Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-alpha chain. Biochemistry, 2001, 40(26):78537859.
[7] Weetman AP. Aatoimmune thyroid disease:propagation and progression. Eur J Endocrinol, 2003, 148(1):1-9.
[8] Rapozzi V, Burm BE, Cogoi S, et al. Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids. Nucleic Acids Res, 2002, 30(17):3712-3721.
[9] 韩曙光,赵浩亮,董胜利,等.反义肽核酸下调树突状细胞CCR7基因表达抑制大鼠肝移植急性排斥反应[J].中华器官移植杂志,2008,29(2):73-77.

相似文献/References:

[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
 Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
 Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[3]郭坤,高蕊,于燕,等.表皮生长因子受体基因表达与甲状腺功能亢进症131I治疗预后的关系[J].国际放射医学核医学杂志,2015,39(1):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
 Guo Kun,Gao Rui,Yu Yan,et al.The relationship between epidermal growth factor receptor mRNA expression and the efficacv of 131I treatment in hyperthyroidism patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):4.[doi:10.3760/cma.j.issn.1673-4114.2015.01.003]
[4]杨洋,樊赛军.LXXLL模体在雌激素受体信号通路中的作用及应用价值[J].国际放射医学核医学杂志,2014,38(1):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
 Yang Yang,Fan Saijun.Role of LXXLL motif in modulation of estrogen receptor signaling and its potential application[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):22.[doi:10.3760/cma.j.issn 1673-4114.2014.01.006]
[5]白庆双,李宁,方佩华,等.人血清TRAb酶联免疫吸附试验检测在甲状腺疾病患者中的临床应用[J].国际放射医学核医学杂志,2014,38(2):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
 Bai Qingshuang,Li Ning,Fang Peihua,et al.The clinical application of human serum level of the TRAb measured by enzyme-linked immunosorbent assay in patients with thyroid diseases[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):80.[doi:10.3760/cma.j.issn.1673-4114.2014.02.003]
[6]李丽,赵长久,田国梅.CXC型趋化因子受体4及其分子显像剂在肿瘤方面的研究进展[J].国际放射医学核医学杂志,2014,38(3):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
 Li Li,Zhao Changjiu,Tian Guomei.Research progress of CXC chemokine receptor type 4 and molecular imaging in tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):190.[doi:10.3760/cma.j.issn.1673-4114.2014.03.012]
[7]周晓靓,王浩,施培基,等.表皮生长因子受体-酪氨酸激酶肿瘤分子显像剂的研究进展[J].国际放射医学核医学杂志,2013,37(2):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
 ZHOU Xiao-liang,WANG Hao,SHI Pei-ji,et al.The developme nt of epidermal growth factor receptor molecular imaging in cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):100.[doi:10.3760/cma.j.issn.1673-4114.2013.02.010]
[8]林美福,陈文新,周硕,等.18F-FES PET/CT显像在雌激素受体阳性乳腺癌诊疗中的初步应用[J].国际放射医学核医学杂志,2013,37(4):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
 LIN Mei-fu,CHEN Wen-xin,ZHOU Shuo,et al.Application of 18F-FES PET/CT in diagnosis and endocrine therapy of patients with estrogen receptorpositive breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):216.[doi:10.3760/cma.j.issn.1673-4114.2013.04.007]
[9]袁杰,刘兴党,韩梅.SPECT、PET神经受体和转运体显像技术在海洛因成瘾研究中的应用[J].国际放射医学核医学杂志,2013,37(1):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
 YUAN Jie,LIU Xing-dang,HAN Mei.Neuroreceptor and its transporters imaging by PET and SPECT in heroin addiction[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(5):30.[doi:10.3760/cma.j.issn.1673-4114.2013.01.009]
[10]鲍伟奇,邱春,管一晖.γ-氨基丁酸A型-苯二氮革受体显像剂在神经系统疾病中的应用[J].国际放射医学核医学杂志,2012,36(1):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]
 BAO Wei-qi,QIU Chun,GUAN Yi-hui.Application of gamma-aminobutyric acid type A-benzodiazepine receptor imaging for study of neuropsychiatric disorders[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(5):1.[doi:10.3760/cma.j.issn.1673-4114.2012.01.001]

备注/Memo

备注/Memo:
收稿日期:2012-06-13。
通讯作者:黄丽娟(Email:tech@tj-bio.com)
更新日期/Last Update: 1900-01-01